411 related articles for article (PubMed ID: 36114073)
1. A rare case of Pseudomonas aeruginosa enteritis induced by pembrolizumab.
Miyamoto M; Tamagawa S; Kono M; Hijiya M; Iyo T; Kinoshita T; Shiga T; Okuda K; Fujishiro T; Ueno M; Mizumoto Y; Kojima F; Ohtani M; Murata SI; Yamaue H; Hotomi M
Auris Nasus Larynx; 2023 Oct; 50(5):836-840. PubMed ID: 36114073
[TBL] [Abstract][Full Text] [Related]
2. Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature.
Oltolini C; Ripa M; Andolina A; Brioschi E; Cilla M; Petrella G; Gregorc V; Castiglioni B; Tassan Din C; Scarpellini P
Mycopathologia; 2019 Feb; 184(1):181-185. PubMed ID: 30101407
[TBL] [Abstract][Full Text] [Related]
3. Pembrolizumab-induced autoimmune side effects of colon and pancreas in a patient with lung cancer.
Ofuji K; Hiramatsu K; Nosaka T; Naito T; Takahashi K; Matsuda H; Ohtani M; Imamura Y; Ishizuka T; Nakamoto Y
Clin J Gastroenterol; 2021 Dec; 14(6):1692-1699. PubMed ID: 34415552
[TBL] [Abstract][Full Text] [Related]
4. Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.
Kato M; Mori M; Miura K; Asao T; Motomura H; Nishino K; Ko R; Koyama R; Hayashi T; Takahashi K
Thorac Cancer; 2021 Nov; 12(22):3076-3079. PubMed ID: 34617405
[TBL] [Abstract][Full Text] [Related]
5. Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab.
Acero Brand FZ; Suter N; Adam JP; Faulques B; Maietta A; Soulières D; Blais N
J Immunother Cancer; 2018 Mar; 6(1):22. PubMed ID: 29548299
[TBL] [Abstract][Full Text] [Related]
6. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
Beck TN; Kudinov AE; Dulaimi E; Boumber Y
BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
[TBL] [Abstract][Full Text] [Related]
7. [A case of severe colitis induced by the administration of pembrolizumab for pulmonary adenocarcinoma in a patient with ulcerative colitis].
Nishimoto N; Sakakibara Y; Ishida H; Ishihara A; Tanaka S; Hasegawa H; Yamamoto S; Nakazuru S; Mori K; Mita E
Nihon Shokakibyo Gakkai Zasshi; 2021; 118(12):1122-1129. PubMed ID: 34897141
[TBL] [Abstract][Full Text] [Related]
8. Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Buti S; Bersanelli M; Perrone F; Bracarda S; Di Maio M; Giusti R; Nigro O; Cortinovis DL; Aerts JGJV; Guaitoli G; Barbieri F; Ferrara MG; Bria E; Grossi F; Bareggi C; Berardi R; Torniai M; Cantini L; Sforza V; Genova C; Chiari R; Rocco D; Della Gravara L; Gori S; De Tursi M; Di Marino P; Mansueto G; Zoratto F; Filetti M; Citarella F; Russano M; Mazzoni F; Garassino MC; De Toma A; Signorelli D; Gelibter A; Siringo M; Follador A; Bisonni R; Tuzi A; Minuti G; Landi L; Ricciardi S; Migliorino MR; Tabbò F; Olmetto E; Metro G; Adamo V; Russo A; Spinelli GP; Banna GL; Addeo A; Friedlaender A; Cannita K; Porzio G; Ficorella C; Carmisciano L; Pinato DJ; Mazzaschi G; Tiseo M; Cortellini A
Eur J Cancer; 2021 Jun; 150():224-231. PubMed ID: 33934059
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma.
Bas O; Ozbek A; Guven D; Aktepe O; Kılıc L; Kertmen N; Erman M
J Oncol Pharm Pract; 2020 Jul; 26(5):1230-1233. PubMed ID: 31735133
[TBL] [Abstract][Full Text] [Related]
10. An HIV-infected Patient with Confirmed Overlapping Complications of Severe Amebic Colitis and CMV Enteritis.
Morikubo H; Saito D; Miura M; Sato T; Minowa S; Ikezaki O; Mitsui T; Sakuraba A; Hayashida M; Fujiwara M; Tokunaga K; Shibahara J; Mori H; Masaki T; Kawai S; Hisamatsu T
Intern Med; 2018 Jul; 57(13):1855-1860. PubMed ID: 29491283
[TBL] [Abstract][Full Text] [Related]
11. [Lupus enteritis: an uncommon manifestation of systemic lupus erythematosus with favourable outcome on corticosteroids].
Thomas G; Ebbo M; Genot S; Bernit E; Mazodier K; Veit V; Lagrange X; Heyries L; Kaplanski G; Schleinitz N; Harlé JR
Rev Med Interne; 2010 Jul; 31(7):493-7. PubMed ID: 20471141
[TBL] [Abstract][Full Text] [Related]
12. Retrobulbar Optic Neuritis Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.
Kawakado K; Tamura T; Nakanishi M; Makimoto G; Kuyama S
Intern Med; 2021 Dec; 60(24):3941-3945. PubMed ID: 34148963
[TBL] [Abstract][Full Text] [Related]
13. [A case of severe enteritis induced by adjuvant chemotherapy for colon cancer].
Mukai S; Endo S; Nakahara K; Takayanagi D; Maeda C; Takehara Y; Omoto T; Wada Y; Kida H; Hidaka E; Ishida F; Tanaka J; Kudo SE
Gan To Kagaku Ryoho; 2014 Apr; 41(4):499-502. PubMed ID: 24743369
[TBL] [Abstract][Full Text] [Related]
14. Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.
Sugano T; Seike M; Funasaka Y; Yoshida M; Takayama R; Okamura K; Nakanishi A; Tanaka T; Takeuchi S; Noro R; Minegishi Y; Kubota K; Saeki H; Gemma A
J Immunother Cancer; 2019 Feb; 7(1):59. PubMed ID: 30813943
[TBL] [Abstract][Full Text] [Related]
15. Disseminated intravascular coagulation in advanced lung adenocarcinoma during first-line pembrolizumab.
Alberti A; Mancin M; Cortinovis D; Bidoli P; Sala L
Immunotherapy; 2020 Jun; 12(9):629-633. PubMed ID: 32418466
[No Abstract] [Full Text] [Related]
16. Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
Hines J; Daily E; Pham AK; Shea CR; Nadeem U; Husain AN; Stadler WM; Reid P
J Med Case Rep; 2021 Mar; 15(1):124. PubMed ID: 33736690
[TBL] [Abstract][Full Text] [Related]
17. Fatal ulcerative enteritis of the small intestine in a patient with ulcerative colitis treated with vedolizumab.
Monasterio C; Schmitt-Gräff A; Pohl M; Truschel T; Warnatz K; Kreisel W; Thimme R; Hasselblatt P
Z Gastroenterol; 2017 Oct; 55(10):1014-1020. PubMed ID: 28655067
[TBL] [Abstract][Full Text] [Related]
18. Pembrolizumab-induced sclerosing cholangitis in a lung adenocarcinoma patient with a remarkable response to chemotherapy: a case report.
Sato K; Hayashi M; Abe K; Fujita M; Takahashi A; Ohira H
Clin J Gastroenterol; 2020 Dec; 13(6):1310-1314. PubMed ID: 32643124
[TBL] [Abstract][Full Text] [Related]
19. [An unusual digestive complication under anti-PD-1 (pembrolizumab)].
Calvani J; Elia R; Battistella M; Delyon J; Vivier-Chicoteau J; Gornet JM; Lebbé C; Baroudjian B; Bertheau P
Ann Pathol; 2020 Jul; 40(4):320-323. PubMed ID: 32107038
[TBL] [Abstract][Full Text] [Related]
20. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
